Occlutech, PFM, Lifetech and Other New Devices. What’s on the Horizon?



Current concepts of transcatheter closure of patent foramen ovale (PFO) are based on the implantation of a double disc occluder. Contemporary devices have shown excellent closure rates and some have been tested in randomized trials with good clinical results. However, the presence of an intracardiac foreign body poses several potential problems: atrial fibrillation, thrombus formation, device fracture, embolisation and erosion. The trend in percutaneous PFO closure is shifting towards new devices which minimize the amount of foreign material left in the atria. This chapter focuses on the latest devices for PFO closure, including experimental devices currently under investigation.


Patent Foramen Ovale Device closure In-tunnel-closure PFM Occlutech Lifetech 


  1. 1.
    Krizanic F, Sievert H, Pfeiffer D, Konorza T, Ferrari M, Hijazi Z, Jung C, Lauten A, Figulla HR. The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects. J Invasive Cardiol. 2010;22(4):182–7.PubMedGoogle Scholar
  2. 2.
    Renkhoff K, Joy S, Lehr T, et al. New PFO devices: PFM medical device. Presented at: Congenital and Structural Interventions. 8–11 July 2010, Frankfurt.Google Scholar
  3. 3.
    Momberger J, Renkhoff K, Joy S, et al. Follow-up on PFM medical device. Presented at: Congenital and Structural Interventions. 23–25 June 2011, Frankfurt.Google Scholar

Copyright information

© Springer-Verlag London 2015

Authors and Affiliations

  1. 1.Division of CardiologyCardioVascular Center FrankfurtFrankfurtGermany

Personalised recommendations